Back

Bleeding risk prediction in a large cohort of patients with atrial fibrillation and cancer: A nationwide cohort study

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Oral anticoagulation in real life Oral Anticoagulation ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Associate Professor Daniele Pastori

Sapienza University of Rome, Rome (Italy)

7 More presentations in this session

Presentation thumbnail
Body mass index from the RE-LY trial: further evidence of the obesity paradox
Doctor M. Jacobs (Stony Brook, US)
Abstract Slides
Presentation thumbnail
Management of atrial fibrillation by different medical specialties in the UK: AF-GEN-UK study
Doctor A. Shantsila (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Oral anticoagulation therapy in atrial fibrillation patients with advanced chronic kidney disease: CODE-AF Registry
Professor H. Yu (Seoul, KR)
Abstract Slides
Presentation thumbnail
Patterns of anticoagulant prescribing and renal function changes in patients with atrial fibrillation
Doctor C. Olesovsky (Toronto, CA)
Abstract Slides
Presentation thumbnail
Comparative validation of the HAS-BLED and the GARFIELD-AF bleeding risk scores in Asian patients with atrial fibrillation: a report from the COOL-AF registry
Doctor P. Chichareon (Hat Yai, TH)
Abstract Slides

Access the full session

Session thumbnail
Oral anticoagulation in real life

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on stroke prevention in atrial fibrillation
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - pro
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources